Evolent Health Inc (NYSE:EVH) shares, rose in value on Thursday, March 27, with the stock price up by 1.90% to the previous day’s close as strong demand from buyers drove the stock to $9.63.
Actively observing the price movement in the last trading, the stock closed the session at $9.45, falling within a range of $9.405 and $9.695. The value of beta (5-year monthly) was 1.494. Referring to stock’s 52-week performance, its high was $33.63, and the low was $8.35. On the whole, EVH has fluctuated by 1.90% over the past month.
With the market capitalization of Evolent Health Inc currently standing at about $1.12 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-19.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 2.07B, with a low estimate of 452M and a high estimate of 468.8M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 460.15M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that EVH’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of EVH currently trading nearly 2.38% and -1.93% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 49.09, while the 7-day volatility ratio is showing 4.10% which for the 30-day chart, stands at 5.80%. Furthermore, Evolent Health Inc (EVH)’s beta value is 1.22, and its average true range (ATR) is 0.50.
A comparison of Evolent Health Inc (EVH) with its peers suggests the former has fared considerably weaker in the market. EVH showed an intraday change of 1.90% in last session, and over the past year, it shrunk by -70.28%%.
Data on historical trading for Evolent Health Inc (NYSE:EVH) indicates that the trading volumes over the past 10 days have averaged 2.17 and over the past 3 months, they’ve averaged 2.48 million. According to company’s latest data on outstanding shares, there are 115.04 million shares outstanding.
Nearly 2.59% of Evolent Health Inc’s shares belong to company insiders and institutional investors own 107.07% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 13.9 million shares as on 2025-03-14, resulting in a short ratio of 3.99. According to the data, the short interest in Evolent Health Inc (EVH) stood at 1357.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 12.33 million. The stock has fallen by -14.40% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the EVH stock heading into the next quarter.
